Haijun Lu

572 total citations
30 papers, 410 citations indexed

About

Haijun Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Haijun Lu has authored 30 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Haijun Lu's work include Head and Neck Cancer Studies (6 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (4 papers). Haijun Lu is often cited by papers focused on Head and Neck Cancer Studies (6 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (4 papers). Haijun Lu collaborates with scholars based in China. Haijun Lu's co-authors include Haiping Jiang, Xinjia He, Lin Zhang, Shanshan Yang, Hui Ju, Qi Wang, Yaokun Chen, Jinpeng Xu, Haiji Wang and Hui Feng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cellular and Molecular Life Sciences.

In The Last Decade

Haijun Lu

24 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haijun Lu China 11 216 126 92 57 44 30 410
Fang‐Yi Huo China 10 142 0.7× 69 0.5× 82 0.9× 36 0.6× 45 1.0× 14 362
Alok Mishra India 7 306 1.4× 164 1.3× 116 1.3× 39 0.7× 35 0.8× 8 488
L. Arriaga United States 6 117 0.5× 93 0.7× 109 1.2× 55 1.0× 28 0.6× 7 343
Jae Kim United States 8 259 1.2× 118 0.9× 117 1.3× 29 0.5× 32 0.7× 16 406
Fang‐Wei Hu Taiwan 11 270 1.3× 172 1.4× 184 2.0× 39 0.7× 33 0.8× 12 469
Lianji Wen China 12 278 1.3× 177 1.4× 141 1.5× 28 0.5× 65 1.5× 22 455
Sabindra K. Samal India 8 369 1.7× 121 1.0× 120 1.3× 27 0.5× 40 0.9× 10 493
Hao Peng China 12 117 0.5× 98 0.8× 251 2.7× 136 2.4× 89 2.0× 31 537
Zixue Xuan China 12 233 1.1× 114 0.9× 107 1.2× 60 1.1× 43 1.0× 34 423

Countries citing papers authored by Haijun Lu

Since Specialization
Citations

This map shows the geographic impact of Haijun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haijun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haijun Lu more than expected).

Fields of papers citing papers by Haijun Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haijun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haijun Lu. The network helps show where Haijun Lu may publish in the future.

Co-authorship network of co-authors of Haijun Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Haijun Lu. A scholar is included among the top collaborators of Haijun Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haijun Lu. Haijun Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
An, Ning, Yongchun Zhang, Haijun Lu, & Xue Yang. (2025). RPMB predicts the disease-free survival of head-and-neck squamous carcinoma after adjuvant concurrent radio-chemotherapy. Frontiers in Genetics. 16. 1585970–1585970.
2.
Wang, Kexin, et al.. (2025). Preliminary investigation of the epigenetic regulation of KMT2D via H3K4me1/H3K27ac in oral squamous cell carcinoma. Cellular and Molecular Life Sciences. 82(1). 237–237.
4.
Zhou, Kai, Haijun Lu, Dapeng Hao, et al.. (2025). Prognostic analysis of inconsistent combinations of HPV and p16 in a Chinese/Asian oropharyngeal squamous cell carcinoma population. Infectious Agents and Cancer. 20(1). 35–35.
5.
Lu, Haijun, et al.. (2024). Clinical application of high‐LET radiotherapy combined with immunotherapy in malignant tumors. SHILAP Revista de lepidopterología. 8(1). 42–46. 7 indexed citations
6.
Fu, Jialei, Xiaojuan Wei, Fei Zhou, et al.. (2024). Polyene phosphatidylcholine enhances the therapeutic response of oxaliplatin in gastric cancer through Nrf2/HMOX1 mediated ferroptosis. Translational Oncology. 43. 101911–101911. 3 indexed citations
7.
Lu, Jingyu, Jie Wang, Shan Yang, et al.. (2024). PiR-hsa-23533 promotes malignancy in head and neck squamous cell carcinoma via USP7. Translational Oncology. 45. 101990–101990. 4 indexed citations
8.
Chen, Xiaohan, Lu Zhang, Haijun Lu, Ye Tan, & Bo Li. (2024). Development and validation of a nomogram to predict cervical lymph node metastasis in head and neck squamous cell carcinoma. Frontiers in Oncology. 13. 1174457–1174457. 1 indexed citations
9.
Li, Bo, et al.. (2023). New advances into cisplatin resistance in head and neck squamous carcinoma: Mechanisms and therapeutic aspects. Biomedicine & Pharmacotherapy. 163. 114778–114778. 26 indexed citations
12.
Wang, Qi, Haiji Wang, Mingming Hu, et al.. (2023). Identification of a six-gene signature to predict survival and immunotherapy effectiveness of gastric cancer. Frontiers in Oncology. 13. 1210994–1210994.
14.
Chen, Xiaohan, Li Sun, Xiaojuan Wei, et al.. (2021). Antitumor effect and molecular mechanism of fucoidan in NSCLC. BMC Complementary Medicine and Therapies. 21(1). 25–25. 20 indexed citations
15.
Tan, Ye, Yuanyuan Zhao, Yongchun Zhang, et al.. (2020). TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer. Journal of Cellular and Molecular Medicine. 24(10). 5491–5500. 31 indexed citations
16.
He, Yanli, Haijun Lu, & Lijuan Zhang. (2019). Serum AFP levels in patients suffering from 47 different types of cancers and noncancer diseases. Progress in molecular biology and translational science. 162. 199–212. 24 indexed citations
17.
Yang, Shanshan, et al.. (2019). Prognostic Significance of Hematological Markers for Patients with Nasopharyngeal Carcinoma: A Meta-analysis. Journal of Cancer. 10(11). 2568–2577. 34 indexed citations
18.
Yu, Ning, Peng Zhang, Li Wang, et al.. (2018). RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma. Oncology Letters. 16(6). 7204–7211. 13 indexed citations
19.
Yang, Shanshan, Xufu Wang, Haiping Jiang, et al.. (2017). Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testing. Cancer Biology & Therapy. 18(10). 757–760. 10 indexed citations
20.
Lu, Haijun, et al.. (2016). Predictive values of TNF-α, IL-6, IL-10 for radiation pneumonitis. Internatuinal Journal of Radiation Research. 14(3). 173–179. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026